Quince Therapeutics
$0.9435
62
-$0.03-3.33% Friday 20:00
+$0.02+1.63%Friday 23:56After hours
Statistics
Day High
0.9496
Day Low
0.9472
52W High
44
52W Low
0.8
Volume
1,753
Avg. Volume
-
Mkt Cap
52.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11AugExpected
Expected EPS
-0.47
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-113.66MNet Income
Analyst Ratings
4.00Average Price Target
The highest estimate is 4.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow QNCX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sangamo Therapeutics
SGMO
Mkt Cap70.43M
CRISPR Therapeutics
CRSP
Mkt Cap5.33B
Editas Medicine
EDIT
Mkt Cap412.81M
Intellia Therapeutics
NTLA
Mkt Cap2.19B
Voyager Therapeutics
VYGR
Mkt Cap228.69M
Protagonist Therapeutics
PTGX
Mkt Cap7.06B
Fate Therapeutics
FATE
Mkt Cap243.61M
Regenxbio
RGNX
Mkt Cap459.07M
About
Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fractures and disease sites. Leading their pipeline is NOV004, an anabolic peptide meticulously designed to pinpoint and accumulate its therapeutic action precisely at bone fracture locations. The company, previously known as Cortexyme, Inc., officially rebranded as Quince Therapeutics, Inc. in August 2022. Established in 2012, Quince Therapeutics is headquartered in South San Francisco, California.
Show more...
CEO
Dr. Dirk Thye M.D.
Employees
36
Country
United States
ISIN
US22053A2069
Listings
0 Comments
Share your thoughts
FAQ
What is Quince Therapeutics stock price today?▼
The current price of QNCX is $0.94 USD — it has decreased by -3.33% in the past 24 hours. Watch Quince Therapeutics stock price performance more closely on the chart.
What is Quince Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quince Therapeutics stocks are traded under the ticker QNCX.
Is Quince Therapeutics stock price growing?▼
QNCX stock has fallen by -0.16% compared to the previous week, the month change is a -17.96% fall, over the last year Quince Therapeutics has showed a -93.91% decrease.
What is Quince Therapeutics market cap?▼
Today Quince Therapeutics has the market capitalization of 52.54M
When is the next Quince Therapeutics earnings date?▼
Quince Therapeutics is going to release the next earnings report on August 11, 2026.
What were Quince Therapeutics earnings last quarter?▼
QNCX earnings for the last quarter are 3.85 USD per share, whereas the estimation was -1.3 USD resulting in a +395.77% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quince Therapeutics revenue for the last year?▼
Quince Therapeutics revenue for the last year amounts to 0 USD.
What is Quince Therapeutics net income for the last year?▼
QNCX net income for the last year is -113.66M USD.
How many employees does Quince Therapeutics have?▼
As of June 27, 2026, the company has 36 employees.
In which sector is Quince Therapeutics located?▼
Quince Therapeutics operates in the Health & Wellness sector.
When did Quince Therapeutics complete a stock split?▼
The last stock split for Quince Therapeutics was on April 13, 2026 with a ratio of 1:10.
Where is Quince Therapeutics headquartered?▼
Quince Therapeutics is headquartered in South San Francisco, United States.